SomatiCA statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Tumor purity and heterogeneity estimation Somatic CNA detection chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

SomatiCA specifications

Information


Unique identifier OMICS_06950
Name SomatiCA
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages R
License GNU General Public License version 2.0
Computer skills Advanced
Version 1.4.0
Stability Stable
Requirements
methods, IRanges, GenomicRanges, DNAcopy, R(>=2.14.0), foreach, doParallel, lars, rebmix, sn
Maintained Yes

Download


Versioning


Add your version

Documentation


Maintainer


  • person_outline Hongyu Zhao <>

Publication for SomatiCA

SomatiCA in publications

 (3)
PMCID: 5225790
PMID: 27958595
DOI: 10.14639/0392-100X-1093

[…] (1) mutazione germinale del gene smarcb1 o del gene lztr1; (2) ampia delezione all'interno del cromosoma 22 (con perdita del gene nf2 e dell'allele intatto smarcb1 o lztr1); e (3) mutazione somatica dell'allele intatto del gene nf2 [meccanismo conosciuto come "four hits": "quadrupla alterazione" (su entrambi gli alleli dei due geni swnts/nf2), con tre passaggi consecutivi]. negli ultimi […]

PMCID: 4335967
PMID: 25729424
DOI: 10.3332/ecancer.2015.511

[…] number of ilp clinical trials that used melphalan. he also pointed out that this technique is now accepted by a number of national bodies., dr ruggerio ridolfi, of immunoterapia e terapia cellulare somatica meldola, gave a talk entitled ‘planning ipilimumab therapy in a single institution’. he identified the immunotherapy unit and the pharmacy unit of the romagna cancer centre as the focus […]

PMCID: 4096026
PMID: 25075214
DOI: 10.3332/ecancer.2014.440

[…] has already been successful with breast, non-small-cell lung carcinoma, and pancreas cancers, and is in phase iii trials for melanoma., ruggero ridolfi from the immunoterapia e terapia cellulare somatica ior meldola started the second half of the third session with a switch back to strategic issues in his talk about implementing ‘drug days’ in an italian hospital to cut costs and save waste […]


To access a full list of publications, you will need to upgrade to our premium service.

SomatiCA institution(s)
Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA; Department of Genetics, Yale University, New Haven, CT, USA; Department of Neurosurgery, Yale University, New Haven, CT, USA; Department of Biostatistics, Yale University, New Haven, CT, USA
SomatiCA funding source(s)
Supported by the NIH grant R01 GM59507.

SomatiCA reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review SomatiCA